IMC Chicago
AZN icon

IMC Chicago’s AstraZeneca AZN Stock Holding History

IMC Chicago’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.3M Sell
191,300
-2,400
-1% -$451K 0.01% 742
2026
Q1 		$38.2M Buy
193,700
+53,500
+38% +$10.3M 0.01% 594
2025
Q4 		$25.8M Buy
140,200
+12,650
+10% +$2.22M 0.01% 737
2025
Q3 		$19.6M Buy
127,550
+22,550
+21% +$3.41M 0.01% 800
2025
Q2 		$14.7M Sell
105,000
-41,250
-28% -$5.78M 0.01% 831
2025
Q1 		$21.5M Buy
146,250
+30,350
+26% +$4.39M 0.01% 543
2024
Q4 		$15.2M Buy
115,900
+51,050
+79% +$7.15M 0.01% 725
2024
Q3 		$10.1M Sell
64,850
-19,350
-23% -$3.12M 0.01% 821
2024
Q2 		$13.1M Buy
84,200
+21,000
+33% +$3.16M 0.01% 679
2024
Q1 		$8.56M Buy
63,200
+10,450
+20% +$1.38M 0.01% 765
2023
Q4 		$7.11M Sell
52,750
-11,450
-18% -$1.49M ﹤0.01% 761
2023
Q3 		$8.7M Buy
64,200
+10,350
+19% +$1.41M 0.01% 589
2023
Q2 		$7.71M Buy
53,850
+18,050
+50% +$2.66M 0.01% 563
2023
Q1 		$4.97M Sell
35,800
-6,200
-15% -$834K 0.01% 650
2022
Q4 		$5.7M Buy
42,000
+1,350
+3% +$169K 0.01% 582
2022
Q3 		$4.46M Sell
40,650
-6,750
-14% -$856K 0.01% 586
2022
Q2 		$6.26M Sell
47,400
-5,950
-11% -$781K 0.01% 517
2022
Q1 		$7.08M Sell
53,350
-24,800
-32% -$2.97M 0.01% 522
2021
Q4 		$9.1M Buy
78,150
+22,700
+41% +$2.67M 0.01% 500
2021
Q3 		$6.66M Sell
55,450
-19,800
-26% -$2.3M 0.01% 572
2021
Q2 		$9.02M Sell
75,250
-20,700
-22% -$2.27M 0.01% 473
2021
Q1 		$9.54M Sell
95,950
-61,000
-39% -$6.13M 0.01% 439
2020
Q4 		$15.7M Buy
156,950
+82,450
+111% +$8.73M 0.02% 317
2020
Q3 		$8.16M Buy
+74,500
New +$8.29M 0.01% 339

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

IMC Chicago's AZN Position: Q2 2026 in Review

IMC Chicago opened a new position in AstraZeneca (AZN) in Q2 2026: 7,754 shares worth $1.47M. The stake represents ﹤0.01% of the portfolio and ranks #3388 among its holdings. This is a return to the name: IMC Chicago previously reported a position in AZN as recently as Q3 2025.

IMC Chicago first reported a position in AZN in Q4 2020 and has held it in 5 quarters since. The position peaked at $3.18M in Q3 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • IMC Chicago held 7,754 shares of AstraZeneca worth $1.47M as of Q2 2026.
  • AstraZeneca was a new IMC Chicago position in Q2 2026.
  • AstraZeneca made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3388 holding.
  • IMC Chicago first reported a position in AstraZeneca in Q4 2020 and has held it in 5 quarters since.
  • IMC Chicago's AstraZeneca position peaked at $3.18M in Q3 2025.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.